Digital Mirror Therapy With Uni- and Bilateral Mirror Visual Feedback After Stroke: Treatment Effects and EEG Evidence

August 28, 2023 updated by: Chang Gung Memorial Hospital

The Use of a New Digital Mirror Therapy System Providing Unilateral and Bilateral Mirror Visual Feedback for Patients With Stroke: Treatment Effects and EEG-physiological Evidence

The specific study aims will be:

  1. To examine the treatment effects of a new digital mirror therapy (MT) system versus a mirror box in patients with stroke by conducting a 4-group randomized controlled trial.
  2. To examine the electrophysiological mechanisms of uni-mirror visual feedback (uni-MVF) condition with unimanual training mode, uni-MVF condition with bimanual training mode, and bi-MVF condition with bimanual training mode in the new MT system by EEG.

Study Overview

Detailed Description

Part I: Validation of Treatment Efficacy of the New Digital MT System with Different MVF Conditions and Training Modes

In this new MT system, 3 different types of MT in different MVF conditions and training modes can be provided: unilateral MVF with unimanual training mode (UM-UT), unilateral MVF with bimanual training mode (UM-BT), and bilateral MVF with bimanual training mode (BM-BT). In the part Ⅰ study, an estimated total of 80 patients with stroke will be recruited. In addition to the original rehabilitation interventions of patients, each participant will be randomly allocated to 1 of 4 intervention groups (i.e., UM-UT, UM-BT, BM-BT, or traditional MT using a mirror box) for 15-hour therapy sessions. Outcome measures will be administrated at pre-treatment, immediately after treatment, and at 1-month follow-up after treatment.

Part II: Investigation of the Electrophysiological Mechanisms Underlying Different MVF Conditions by EEG

Twenty stroke patients will be recruited for examining the brain electrophysiological mechanisms underlying different types of MVF and training conditions of this new system by using electroencephalography (EEG). Three experimental conditions, including UM-UT, UM-BT, and BM-BT conditions, will be conducted in the EEG study.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Taoyuan City, Taiwan, 333
        • Recruiting
        • Taoyuan Chang Gung Memorial Hospital
        • Contact:
    • Taoyuan
      • Taoyuan City, Taoyuan, Taiwan, 333
        • Recruiting
        • Lo-Sheng Sanatorium and Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Part Ⅰ: Validation of Treatment Efficacy of the New Digital MT System with Different MVF Conditions and Training Modes

Inclusion Criteria:

  • diagnosed with a unilateral stroke;
  • at least 6 months after stroke onset;
  • age between 20 and 80 years old;
  • having a baseline score of Fugl-Meyer Assessment (FMA) in a range of 20 to 60;
  • able to follow the study instructions;
  • capable of participating in therapy and assessment sessions

Exclusion Criteria:

  • global or receptive aphasia;
  • severe neglect measured by line bisection test;
  • other major medical diseases or comorbidities that have influenced upper-limb usage or caused severe pain

Part II: Investigation of the Electrophysiological Mechanisms Underlying Different MVF Conditions by EEG

Inclusion Criteria:

  • diagnosed with a unilateral stroke;
  • at least 2 weeks after stroke onset and medical stable;
  • aged 20 to 80 years;
  • having a baseline score of FMA ≥ 40 and wrist flexion ≥ 20 degrees in order to perform EEG motor tasks;
  • both wrist flexion and extension scores of Modified Ashworth Scale ≤ 1;
  • able to follow the study instructions

Exclusion Criteria:

  • global or receptive aphasia;
  • severe neglect measured by line bisection test;
  • other major medical diseases or comorbidities, such as neurological and psychiatric diseases, that have caused severe pain of upper-limb or interfered brain neural activities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Uni-MVF condition and unimanual training mode using the new MT system (UM-UT)
The following common categories of upper-limb movements and actions will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movements, and (c) object manipulation.
For the UM-UT group, the participants will be seated in front of the new MT system, and will be instructed to watch the real-time image reflection of movements of the non-affected arm and hand on the screen carefully. At the same time, the patients will need to imagine that the movements were performed by their affected arm and hand. In this group, only the non-affected arm and hand will need to perform the movements, but the affected one will not need to move.
Experimental: Uni-MVF condition and bimanual training mode using the new MT system (UM-BT)
The following common categories of upper-limb movements and actions will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movements, and (c) object manipulation.
During the UM-BT, as similar as the first group (UM-UT), the participants will be also seated in front of the new MT system, and be instructed to watch the real-time image reflection of the non-affected arm and hand's movements on the screen carefully and imagine that the movements were performed by the affected arm. However, in this UM-BT group, the bilateral training mode is emphasized, and thus both arms and hands will need to move. That is, during therapy, the patient's affected arm and hand will be required to move at his/her best motor ability with the non-affected arm and hand at the same time.
Experimental: Bi-MVF condition and bimanual training mode using the new MT system (BM-BT)
The following common categories of upper-limb movements and actions will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movements, and (c) object manipulation.
For the BM-BT group, the participants will be seated in front of this new MT system, and be instructed to observe the real-time image reflection of the non-affected arm and hand's movements transformed and superimposed on both arms and hands (i.e., bi-MVF), and to imagine that the movements were performed by both arms and hands. In this group, bi-MVF and bilateral training mode are emphasized, and thus both arms and hands will also need to move. The patient's affected arm and hand will be required to move as could as possible simultaneously.
Active Comparator: Traditional MT using a mirror box
The following common categories of upper-limb movements and actions will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movements, and (c) object manipulation.
During traditional MT, the participants will be seated in front of a mirror box placed at their mid-sagittal plane. The affected arm and hand of the participants will be placed inside the mirror box, and the non-affected arm and hand will be in front of the mirror. As similar to the UM-UT group, the participants will be instructed to watch the mirror reflection of the movements performed by the non-affected arm and hand carefully and to imagine that the movements were performed by the affected arm and hand. In this group, the patient's affected arm and hand inside the mirror box will not need to move.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change scores of Fugl-Meyer Assessment
Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
The upper-limb subsection of Fugl-Meyer Assessment is a measure with sound psychometric properties to evaluate motor impairments.
baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
Change scores of Chedoke Arm and Hand Activity Inventory
Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
The Chedoke Arm and Hand Activity Inventory is a reliable and validated measure to assess the independence of stroke patients to perform activities of daily living with an affected upper limb.
baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change scores of Box and Block Test
Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
The Box and Block Test is a tool with sound reliability and validity to evaluate hand dexterity of stroke patients.
baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
change scores of Revised Nottingham Sensory Assessment
Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
The Revised Nottingham Sensory Assessment is a standardized measure with good reliability to assess sensory function in patients with stroke.
baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
change scores of Movement Imagery Questionnaire-Revised, Second Edition
Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
The Movement Imagery Questionnaire-Revised, Second Edition is a 14-item questionnaire with sound reliability and validity to evaluate the ability of motion imagination in patients with stroke.
baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
change scores of Barthel Index
Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
The Barthel Index is a validated tool designed to measure activities reflecting the daily living independence.
baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
change scores of Motor Activity Log
Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
The Motor Activity Log is a semi-structured interview with good psychometric properties to assess the level of use of affected upper limb in 30 main activities of daily living.
baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
change scores of the health state of EQ-5D-5L
Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
The questionnaire of EQ-5D-5L contains 5 dimensions, including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, and uses a 5-point Likert scale scored from 1 (no problem) to 5 (unable to/extreme problems); whereas, the numerical description of 5 dimensions represents the health state.
baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
change scores of the visual analogue scale (VAS) of EQ-5D-5L
Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)
The VAS of EQ-5D-5L scores will be scored from 0 to 100, with a higher score indicating better overall current health.
baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yu-Wei Hsieh, PhD, Department of Occupational Therapy, College of Medicine, Chang Gung University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2021

Primary Completion (Estimated)

July 31, 2024

Study Completion (Estimated)

July 31, 2024

Study Registration Dates

First Submitted

March 21, 2021

First Submitted That Met QC Criteria

March 23, 2021

First Posted (Actual)

March 24, 2021

Study Record Updates

Last Update Posted (Actual)

August 30, 2023

Last Update Submitted That Met QC Criteria

August 28, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

3
Subscribe